In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo
Alexis Kays Leonard, Anthony P. Sileno, Gordon C. Brandt, Charles A. Foerder, Steven C. Quay, Henry R. CostantinoVolume:
335
Année:
2007
Langue:
english
Pages:
9
DOI:
10.1016/j.ijpharm.2006.11.013
Fichier:
PDF, 372 KB
english, 2007